EA199900298A1 - Средство для воздействия на организм - Google Patents

Средство для воздействия на организм

Info

Publication number
EA199900298A1
EA199900298A1 EA199900298A EA199900298A EA199900298A1 EA 199900298 A1 EA199900298 A1 EA 199900298A1 EA 199900298 A EA199900298 A EA 199900298A EA 199900298 A EA199900298 A EA 199900298A EA 199900298 A1 EA199900298 A1 EA 199900298A1
Authority
EA
Eurasian Patent Office
Prior art keywords
influencing
Prior art date
Application number
EA199900298A
Other languages
English (en)
Other versions
EA001601B1 (ru
Inventor
Олег Ильич ЭПШТЕЙН
Original Assignee
Олег Ильич ЭПШТЕЙН
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Олег Ильич ЭПШТЕЙН filed Critical Олег Ильич ЭПШТЕЙН
Publication of EA199900298A1 publication Critical patent/EA199900298A1/ru
Publication of EA001601B1 publication Critical patent/EA001601B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Addiction (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
EA199900298A 1996-09-30 1997-09-29 Средство для воздействия на организм EA001601B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU96118931A RU2132181C1 (ru) 1996-09-30 1996-09-30 Средство для воздействия на организм
PCT/RU1997/000305 WO1998014162A1 (fr) 1996-09-30 1997-09-29 Agent permettant d'agir sur l'organisme

Publications (2)

Publication Number Publication Date
EA199900298A1 true EA199900298A1 (ru) 1999-08-26
EA001601B1 EA001601B1 (ru) 2001-06-25

Family

ID=20185731

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199900298A EA001601B1 (ru) 1996-09-30 1997-09-29 Средство для воздействия на организм

Country Status (5)

Country Link
AU (1) AU4729397A (ru)
EA (1) EA001601B1 (ru)
RU (1) RU2132181C1 (ru)
UA (1) UA57042C2 (ru)
WO (1) WO1998014162A1 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2181297C2 (ru) 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
WO2003072105A1 (en) 2002-02-28 2003-09-04 Sempach Pty Ltd Treatment of effect of chemicals with their ultradilute stereoisomers
UA76639C2 (ru) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатическое лекарственное средство и способ лечения эректильных дисфункций
RU2309732C1 (ru) 2006-03-13 2007-11-10 Олег Ильич Эпштейн Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
CA2804964C (en) 2010-07-15 2016-06-28 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
RU2541167C2 (ru) * 2013-03-29 2015-02-10 Александр Николаевич Куршев Способ лечения аддикции
WO2015130191A1 (ru) * 2014-02-25 2015-09-03 Анатолий Викторович ЗАЗУЛЯ Устройство специфических антидотов аллопатическими лекарственными средствами в общей внешней (вторичной) упаковке

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2074700C1 (ru) * 1993-03-10 1997-03-10 Наталья Борисовна Зубова Способ получения биологически активного препарата
RU2043768C1 (ru) * 1994-05-24 1995-09-20 Алексей Владимирович Попов Способ лечения алкоголизма
RU2030910C1 (ru) * 1994-08-11 1995-03-20 Григорий Семенович Черныш Средство для воздействия на организм
RU2084217C1 (ru) * 1996-02-12 1997-07-20 Эпштейн Олег Ильич Лекарственное средство

Also Published As

Publication number Publication date
RU2132181C1 (ru) 1999-06-27
UA57042C2 (ru) 2003-06-16
WO1998014162A1 (fr) 1998-04-09
EA001601B1 (ru) 2001-06-25
AU4729397A (en) 1998-04-24

Similar Documents

Publication Publication Date Title
NO971041D0 (no) Brönn-frakoplingsverktöy
DE69722386D1 (de) Optischer körper
DE69708009D1 (de) Fahrzeugkarosserie
IS4912A (is) Umbúðir fyrir hollegg
DE69517659T2 (de) Verbinder
DE69518960T2 (de) Verbinder
DE59605335D1 (de) Muldenkörper
DE69708016T2 (de) Kraftfahrzeugkarosserie
DE69523489D1 (de) Verbinder
DE69521660D1 (de) Verbinder
DE59711146D1 (de) Cpkd-karosserie
EA199900298A1 (ru) Средство для воздействия на организм
DE69721502D1 (de) Fräserkörper
DE59701536D1 (de) Fibrillationsarmer formkörper
NO993024L (no) Polysakkarid-peptid-derivater
DE69421614T2 (de) Gleitkörper
DE59506610D1 (de) Gusskörper
KR980000678U (ko) 반신 좌욕기
KR970056920U (ko) 시신안치대
FIU970449U0 (fi) Runkotolppa
KR970060702U (ko) 시신안치용 매트
FI962500A0 (fi) Formeri
SE9602256D0 (sv) Karosseribalk
TR199600158A1 (tr) Mekavizyon
FI974357A (fi) Seuraajaelin

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM RU

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY